English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Getting ready for ASH 2024 - Plan your CML Sessions
November 2024 - Only a few weeks to go until the 66th Annual Meeting of the American Society of Hematology (ASH). This year the meeting is held in San Diego, USA, and online from December 7-10th.
With nearly 8,000 abstracts, this largest hematology event of the year is a must-attend for the latest in hematology research, including important updates on CML.
To help you plan your CML meeting schedule, we have compiled a list of sessions on CML for your convenience including oral sessions, posters presentations and a Satellite Symposium on Friday. And… don’t forget the iCMLf Forum on Advancing Treatment Free Remission globally on the 7th December at 12pm. Register here.
Members of the iCMLf team will be on-site, so if you'd like to arrange a meeting, please reach out at info@cml-foundation.org.
We look forward to connecting with you in San Diego.
Learn more...
Personal perspectives on CML from the 2024 iCMLf prize recipients
October 2024 - The recipients of the three 2024 iCMLf Prizes received their medals at the recent ESH-iCMLf 26th John Goldman Conference on CML: Biology and Therapy. During their acceptance speeches they shared insights into their incredible work which has significantly shaped the way we understand and treat CML today.
The keynote presentations of the 2024 prize recipients are now available to view on the iCMLf website, and they reflect the innovation, compassion, and dedication of all three prize winners across CML research, treatment, and patient advocacy.
You can listen to Professor Neil Shah’s personal view on the challenges of treatment resistance, Professor Jeff Lipton exploring the therapeutic goals of CML from the perspectives of both physicians and patients, and Viji Venkatesh share her powerful account of collaborative efforts in CML patient support and community-building.
Highlights from the 2024 ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy
The ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy, held in Prague, brought together world-leading experts to discuss the latest advancements in the treatment and biology of CML. Jointly organised bythe European School of Haematology (ESH) and the iCMLf , the event featured cutting-edge research presentations, insightful discussions, and collaborative sessions focused on driving innovation in CML management.
2024 John Goldman Fun Run - Thank you for your support!
Thanks to everyone who supported the 2024 John Goldman Fun Run, held during the recent ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy in Prague.
Despite the cold morning, the warmth of camaraderie and the fun we shared among the around 50 enthusiastic runners joining us on the 5-km route through Potviní Park made it an unforgettable experience!
Together, we raised $2,200– a heartfelt thank you to all 64 individual supporters.
The funds raised will directly support our mission to improve outcomes for people living with CML in low- and middle-income countries, ensuring that physicians in these regions can continue to access the vital training and education needed to make a difference in patient care.
Read more...
REMINDER: Highlights of the John Goldman Conference on CML from Jorge Cortes & Daniela Krause on Oct 8th
The recently concluded ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy featured an exciting, cutting-edge, scientific program. This is a friendly reminder to attend the webinar with highlights of this meeting next Tuesday, October 8th at 13.00 CEST.
This live webinar is part of our ongoing iCMLf Conversations series
Your dial-in link for Zoom: https://us02web.zoom.us/j/85295994086
Expect highlights on new and often unpublished data, and the most innovative developments in CML – presented to you by Professors Jorge Cortes and Daniela Krause, both co-chairs of the conference. Some of the key sessions included new therapeutic approaches, TKI responses and biomarkers, progenitor cells and immunology, and the latest in blast phase CML treatments.
Highlights from the ESH-iCMLf 26th Annual John Goldman Conference on CML: Biology and Therapy
We're bringing you highlights from the conference with a summary of selected scientific sessions. Check back over the next couple of days for updates on more sessions.
🌟 Scientific Session: Top scoring abstracts 🌟
This Scientific Session presented six top-scoring abstracts selected by the meeting organisers. These presentations highlighted key advancements in understanding the mechanisms of disease progression, the clinical implications of mutations, and factors driving relapse after CML cessation.
During this session, the best biological abstract was awarded to Daniele Sarnello for his work on BNIP3 as a potential therapeutic target in hypoxic CML cells, while the best clinical abstract went to Kendra Sweet, who presented results of the SWOG trial on the addition of ruxolitinib to BCR::ABL1 TKIs.
